Cannabinoids for pain management

Adam Thaler, Anita Gupta, Steven Cohen

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Cannabinoids have been used for thousands of years to provide relief from suffering, but only recently have they been critically evaluated in clinical trials. This review provides an in- depth examination of the evidence supporting cannabinoids in various pain states, along with an overview of potential adverse effects. In summary, there is strong evidence for a moderate analgesic effect in peripheral neuropathic and central pain conditions, and conflicting evidence for their use in nociceptive pain. For spasticity, most controlled studies demonstrate significant improvement. Adverse effects are not uncommon with cannabinoids, though most are not serious and self- limiting. In view of the limited effect size and low but not inconsequential risk of serious adverse events, cannabinoids should be employed as analgesics only when safer and more effective medication trials have failed, or as part of a multimodal treatment regimen.

Original languageEnglish (US)
Title of host publicationChronic Pain and Addiction
PublisherS. Karger AG
Pages126-138
Number of pages13
Volume30
ISBN (Print)9783805597265, 9783805597258
DOIs
StatePublished - Apr 20 2011

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Cannabinoids for pain management'. Together they form a unique fingerprint.

  • Cite this

    Thaler, A., Gupta, A., & Cohen, S. (2011). Cannabinoids for pain management. In Chronic Pain and Addiction (Vol. 30, pp. 126-138). S. Karger AG. https://doi.org/10.1159/000324070